Simona Skerjanec's most recent trade in Avidity Biosciences Inc was a trade of 10,034 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 10, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Avidity Biosciences Inc | Simona Skerjanec | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 10,034 | 10,034 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Simona Skerjanec | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 6,692 | 6,692 | - | 0 | Common Stock | |
| Immunic Inc | Simona Skerjanec | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 150,000 | 150,000 | - | - | Stock Option | |
| Immunic Inc | Simona Skerjanec | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jul 2024 | 100,000 | 100,000 | - | - | Stock Option | |
| Immunic Inc | Simona Skerjanec | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jul 2024 | 50,000 | 50,000 | - | - | Stock Option | |
| Avidity Biosciences Inc | Simona Skerjanec | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2024 | 42,308 | 42,308 | - | - | Stock Option (Right to Buy) |